Axsome Therapeutics, Inc. Equity-NMS: AXSM

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :

$41.21

52W high :

$66.13

1Y :

-35.6%

5Y :

667.45%

Shares O/S :

38.91 M

Market cap :

1.65 B

What is the share price of Axsome Therapeutics, Inc. today?

Axsome Therapeutics, Inc. (AXSM) share price as of July 6, 2022, is $0. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Axsome Therapeutics, Inc.?

Yes, Indian Investors can invest in the Axsome Therapeutics, Inc. (AXSM) Share by opening an international trading account with Angel One.

How can I purchase Axsome Therapeutics, Inc. shares in India?

Purchasing Axsome Therapeutics, Inc. (AXSM) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying Axsome Therapeutics, Inc. (AXSM) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Axsome Therapeutics, Inc.?

Yes, you can purchase fractional shares of Axsome Therapeutics, Inc. (AXSM) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Axsome Therapeutics, Inc.?

The market capitalization of Axsome Therapeutics, Inc. on July 6, 2022, is $1.64 B.

In which sector Axsome Therapeutics, Inc. belongs?

Axsome Therapeutics, Inc. operates in the Healthcare sector, specifically in the Biotechnology industry.

What documents are required to invest in Axsome Therapeutics, Inc. stocks?

In order to invest in Axsome Therapeutics, Inc. (AXSM) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

Axsome Therapeutics, Inc. is a biopharmaceutical company. The Company is developing novel therapies for central nervous system (CNS) disorders for which there are limited treatment options. It is developing products that meaningfully improve the lives of patients and provide new therapeutic options for physicians. The Company's CNS portfolio includes four product candidates, such as AXS-05, AXS-07, AXS-12, and AXS-14. AXS-05 is being developed for the treatment of major depressive disorder (MDD), Alzheimer's disease agitation (AD agitation), and smoking cessation. AXS-07 is a novel, oral, rapidly absorbed, multi-mechanistic, investigational medicine under development for the acute treatment of migraine. AXS-12 is an investigational medicine in development for the treatment of narcolepsy. The Company also provides Sunosi, which is dual-acting dopamine and norepinephrine reuptake inhibitor indicated to improve wakefulness in adult patients.